soul trial oral semaglutide cardiovascular outcomes results 2024 nejm 2025 The (Semaglutide Trial) was a randomized Optimal Medical Therapy Targeting Metabolic

Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet

A major finding of the study shows that participants receiving the highest dose of retatrutide achieved an average weight loss of 28.3% of their body weight over 80 weeks

Distorted Sweetness: Some users report an increased sensitivity to sweet tastes, making sugary foods overwhelmingly sweet

This potential is most likely to be realized when GLP-1 RA based therapies are embedded within structured, stepped-care frameworks that integrate nutritional, psychological, and social dimensions

The heart had the second-highest number, however

Melanonychia, melanocytic hyperplasia, and nail melanoma in a Hispanic population